CCA
KURA icon

Cygnus Capital Advisors’s Kura Oncology KURA Stock Holding History

Cygnus Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15 Hold
1,788
– – 0.01% 92
2025
Q4 		$19 Buy
+1,788
New +$18.8K 0.01% 72

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cygnus Capital Advisors's KURA Position: Q1 2026 in Review

Cygnus Capital Advisors held its Kura Oncology (KURA) position steady in Q1 2026 at 1,788 shares worth $15. The position accounts for 0.01% of the portfolio, ranked #92.

Cygnus Capital Advisors first reported a position in KURA in Q4 2025 and has held it in 2 quarters since. The position peaked at $19 in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Cygnus Capital Advisors held 1,788 shares of Kura Oncology worth $15 as of Q1 2026.
  • Cygnus Capital Advisors left its Kura Oncology share count unchanged in Q1 2026.
  • Kura Oncology made up 0.01% of Cygnus Capital Advisors's portfolio in Q1 2026, its #92 holding.
  • Cygnus Capital Advisors first reported a position in Kura Oncology in Q4 2025 and has held it in 2 quarters since.
  • Cygnus Capital Advisors's Kura Oncology position peaked at $19 in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Cygnus Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.